E10.3532 Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, left eye

Name of the Condition

Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, left eye

Summary

Type 1 diabetes mellitus is an autoimmune condition characterized by insufficient insulin production. When complicated by proliferative diabetic retinopathy with traction retinal detachment not involving the macula, abnormal blood vessel growth occurs on the retina, leading to fibrous tissue formation that pulls the retina away from its underlying layers. This detachment spares the macula, the central part of the retina responsible for sharp vision, but still poses a risk of vision impairment if not managed promptly.

Causes

Type 1 diabetes results from an autoimmune response targeting insulin-producing pancreatic cells. Proliferative diabetic retinopathy with traction retinal detachment develops due to prolonged hyperglycemia, which damages retinal blood vessels and triggers abnormal vessel growth. The underlying diabetes drives the retinal changes, including the formation of fibrous scar tissue that exerts traction on the retina, leading to detachment.

Risk Factors

• Long duration of diabetes.
• Poor glycemic control.
• Hypertension.
• Dyslipidemia.
• Smoking.

Symptoms

• Sudden or progressive vision loss.
• Blurry or distorted peripheral vision.
• Floaters or dark spots in the visual field.
• Difficulty with night vision.

Diagnosis

Diagnosis involves a comprehensive eye examination, including dilated retinal evaluation and imaging (e.g., optical coherence tomography or fluorescein angiography) to assess retinal neovascularization and traction. Blood tests for glycemic control (e.g., HbA1c) confirm diabetes status.

Treatment Options

• Intensive glycemic control to slow progression.
• Anti-VEGF injections to reduce abnormal blood vessel growth.
• Laser photocoagulation to treat neovascularization.
• Surgical intervention (e.g., vitrectomy) to repair traction retinal detachment.

Prognosis and Follow-Up

Prognosis depends on timely intervention and glycemic management. Regular ophthalmologic follow-up is essential to monitor retinal changes and prevent further vision loss. Early treatment improves outcomes, but residual vision impairment may occur.

Complications

• Permanent vision loss.
• Macular edema (if detachment progresses).
• Retinal tears or complete detachment.
• Increased risk of glaucoma.

Lifestyle & Prevention

• Maintain strict glycemic control through diet, exercise, and insulin therapy.
• Regular eye examinations to detect early retinopathy.
• Manage blood pressure and cholesterol levels.
• Avoid smoking and limit alcohol intake.

When to Seek Professional Help

Seek immediate medical attention for sudden vision changes, increased floaters, or persistent eye pain. Routine follow-up with an ophthalmologist is critical for ongoing monitoring.

Tips for Medical Coders

Document the specific eye (left) and confirm the absence of macular involvement. Ensure clinical notes support the presence of proliferative diabetic retinopathy with traction retinal detachment. Verify that the code aligns with the documented anatomical and pathological details.